Ewelina Powroźniak
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ewelina Powroźniak has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Karol Spozowski
Uniwersytet Medyczny w Lublinie
2 shared publications - Karolina Raksa
Student, Wydział Lekarski, Uniwersytet Medyczny w Lublinie Studenckie Koło Naukowe przy Katedrze i Zakładzie Epidemiologii i Metodologii Badań Klinicznych
2 shared publications - Marcin Czarkowski
Medical University of Lublin
2 shared publications - Paulina Oleksa
Uniwersytet Medyczny w Lublinie
1 shared publication
Latest Publications
- Open Access
- 26 August 2022
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 12 (9) , 361-375
Influence of physical activity, diet, psychic stress and other diseases on psoriaris
Introduction and objective: Psoriasis is a chronic inflammatory skin disease characterized by improperly differentiating epidermal keratinocytes. It may be associated with many coexisting diseases, mainly of the digestive, circulatory and autoimmune systems. Materials and methods: Pubmed database was searched. The criteria for qualifying the articl for the review were the following keywords: psoriasis, diet, sport, exercises, stress. 20 articles from 2017 to 2022 were analyzed. Description of the state of knowledge: Psoriasis has many links with metabolism, which depends on diet, exercise, and other diseases in the body. The excessive amount of pro-inflammatory substances can be regulated by supplying the body with anti-inflammatory ingredients in the diet as well as by physical activity that reduces the level of visceral fat. Many other diseases related to, inter alia, inflammation of the intestines or the state of the intestinal microbiota also affect the systemic distribution of cytokines and adipokines. An important factor influencing health is also mental stress and even epigenetic factors. Summary: Increased physical activity helps fight the main consequences of psoriasis. A similar effect is demonstrated by a low-calorie diet with a high content of anti-inflammatory ingredients and antioxidants and avoidance of pro-inflammatory substances. Treating other comorbidities and maintaining a low level of mental stress also have a positive effect on patients with psoriasis. All of the above interventions are effective complementary to pharmacological therapy.
- 26 August 2022
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 12 (9) , 361-375
Open AccessInfluence of physical activity, diet, psychic stress and other diseases on psoriaris
Introduction and objective: Psoriasis is a chronic inflammatory skin disease characterized by improperly differentiating epidermal keratinocytes. It may be associated with many coexisting diseases, mainly of the digestive, circulatory and autoimmune systems. Materials and methods: Pubmed database was searched. The criteria for qualifying the articl for the review were the following keywords: psoriasis, diet, sport, exercises, stress. 20 articles from 2017 to 2022 were analyzed. Description of the state of knowledge: Psoriasis has many links with metabolism, which depends on diet, exercise, and other diseases in the body. The excessive amount of pro-inflammatory substances can be regulated by supplying the body with anti-inflammatory ingredients in the diet as well as by physical activity that reduces the level of visceral fat. Many other diseases related to, inter alia, inflammation of the intestines or the state of the intestinal microbiota also affect the systemic distribution of cytokines and adipokines. An important factor influencing health is also mental stress and even epigenetic factors. Summary: Increased physical activity helps fight the main consequences of psoriasis. A similar effect is demonstrated by a low-calorie diet with a high content of anti-inflammatory ingredients and antioxidants and avoidance of pro-inflammatory substances. Treating other comorbidities and maintaining a low level of mental stress also have a positive effect on patients with psoriasis. All of the above interventions are effective complementary to pharmacological therapy.
- Open Access
- 26 August 2022
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 12 (9) , 319-327
Impact of SGLT2 inhibitors treatment on the chronic kidney disease in people with type 2 diabetes
Diabetes is the most common cause of CKD (chronic kidney disease). CKD is also one of the most important diabetic complication. SGLT2 (sodium glucose co‐transporter‐2) inhibitors are new class of medication used to lower high blood glucose level in people with type 2 diabetes. In new researches SGLT2 inhibitors demonstrated a significant and clinically relevant reduction in the risks of albuminuria and progression of nephropathy, doubling of serum creatinine levels, and initiation of renal replacement therapy. This review focuses on the therapeutic effectiveness of using SGLT2 inhibitors for the treatment of CKD in type 2 diabetes.
- 26 August 2022
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 12 (9) , 319-327
Open AccessImpact of SGLT2 inhibitors treatment on the chronic kidney disease in people with type 2 diabetes
Diabetes is the most common cause of CKD (chronic kidney disease). CKD is also one of the most important diabetic complication. SGLT2 (sodium glucose co‐transporter‐2) inhibitors are new class of medication used to lower high blood glucose level in people with type 2 diabetes. In new researches SGLT2 inhibitors demonstrated a significant and clinically relevant reduction in the risks of albuminuria and progression of nephropathy, doubling of serum creatinine levels, and initiation of renal replacement therapy. This review focuses on the therapeutic effectiveness of using SGLT2 inhibitors for the treatment of CKD in type 2 diabetes.